The Anifrolumab PRIM Program

Clinical trial NCT06795893 · RECRUITING

Trial details

NCT number: NCT06795893
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Systemic Lupus Erythematosus

Start date: 2025-11-07
Primary completion: 2031-04-15
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.